Cardiac Preconditioning with Sevoflurane
Sevoflurane should be administered continuously throughout cardiac surgery at 0.5-3% (approximately 0.25-0.5 MAC minimum for cardioprotection) rather than as isolated preconditioning or postconditioning periods, as continuous administration provides superior myocardial protection with reduced troponin release and shorter ICU stays. 1, 2, 3
Recommended Protocol
Dosage and Timing
Continuous administration protocol is most effective:
- Concentration: 0.5-3% sevoflurane (approximately 0.25-0.5 MAC demonstrated in animal models for cardioprotection) 1, 4
- Timing: From sternotomy through completion of surgery, not just isolated preconditioning periods 3
- Administration: Can be delivered with or without nitrous oxide through any anesthesia circuit 4
The evidence strongly indicates that timing matters critically. A landmark study by De Hert et al. demonstrated that sevoflurane administered throughout surgery decreased troponin I and ICU length of stay compared to propofol, whereas isolated preconditioning or postconditioning periods showed no benefit 1, 2, 3. This finding is reinforced by research showing that two cycles of 5-minute sevoflurane preconditioning (interspersed with 5-minute washout) reduced troponin I by approximately 50%, while a single 5-minute cycle provided no protection 5.
Mechanism and Evidence Base
The ACC/AHA guidelines (Class IIa recommendation, Level B evidence) state it is beneficial to use volatile anesthetic agents during noncardiac surgery for maintenance of general anesthesia in hemodynamically stable patients at risk for myocardial ischemia 2. This recommendation extends to cardiac surgery based on 15 randomized trials showing:
- Decreased troponin release in 6 trials
- Preserved early LV function in 5 trials
- Decreased ICU length of stay in 1 trial
- Decreased late cardiac events in 1 trial 6, 1, 7
Important caveat: None of these trials were powered to evaluate MI or death as primary outcomes 1, 2.
Contraindications and Precautions
Hemodynamic Considerations
Sevoflurane causes dose-dependent decreases in blood pressure through myocardial contractility depression and afterload reduction 4. Monitor closely and reduce concentration if excessive hypotension or respiratory depression occurs, as these relate directly to anesthetic depth 4.
Drug Interactions Requiring Vigilance
- Epinephrine: Increases risk of ventricular arrhythmias—have emergency antiarrhythmmic medications readily available 4
- Calcium channel blockers: May cause marked hypotension—monitor blood pressure closely and prepare vasopressors 4
- Neuromuscular blocking agents: Sevoflurane potentiates nondepolarizing muscle relaxants (vecuronium, pancuronium, atracurium) similarly to isoflurane—do NOT reduce initial intubating doses, but reduce maintenance doses 4
Specific Warnings
Desiccated CO₂ absorbents: Replace if suspected, as exothermic reactions with sevoflurane increase with desiccation, with rare reports of extreme heat, smoke, or fire in breathing circuits 4
Hepatic function: Use clinical judgment in patients with underlying hepatic conditions or those receiving hepatotoxic drugs, as cases of hepatic dysfunction have been reported 4
Alternative Strategies
When Sevoflurane May Not Be Optimal
Recent evidence from 2022 cardiac surgery guidelines indicates that volatile anesthetics without strict protocols did not decrease 1-year mortality, ICU stay, or hospital length of stay compared to intravenous agents 8. A 2007 study found that 15 minutes of 1 MAC sevoflurane preconditioning provided only limited protection, suggesting this duration may be too short or concentration too low 9.
Propofol Considerations
Critical interaction: Propofol specifically abrogates protection from remote ischemic conditioning in cardiac surgery patients, unlike sevoflurane and isoflurane 10. If investigating or utilizing remote ischemic conditioning strategies, propofol must be avoided 10.
Balanced Approach
For patients where continuous volatile anesthesia is contraindicated:
- Total intravenous anesthesia with propofol and opioids remains acceptable
- High-dose opioid techniques provide cardiovascular stability but may prolong mechanical ventilation and ICU stay 6, 1
- Consider neuraxial techniques for appropriate surgical procedures, though these don't influence MI or mortality in cardiac surgery 1
Practical Implementation
Monitor depth of anesthesia carefully, as sevoflurane's low blood solubility means hemodynamic changes occur more rapidly than with other volatile agents 4. The MAC values decrease with age (from 3.3% in neonates to 1.4% at age 80) and are reduced approximately 50% in adults when combined with 50% N₂O 4.
Key pitfall to avoid: Do not use isolated brief preconditioning periods (e.g., 5-15 minutes before cardiopulmonary bypass) expecting significant cardioprotection—the evidence shows this approach is ineffective 9, 3, 11. The protective effect requires continuous administration throughout the procedure 3.